Diiodothyronines

These metabolites of THYROXINE are formed by the deiodination of T3 or reverse T3.

Networked: 4 relevant articles (1 outcomes, 1 trials/studies)

1.	Non-alcoholic Fatty Liver Disease 01/01/2015 - "Further study will be necessary before diiodothyronines can be considered an effective treatment for NAFLD and dyslipidemia. "
2.	Dyslipidemias (Dyslipidemia) 01/01/2015 - "Further study will be necessary before diiodothyronines can be considered an effective treatment for NAFLD and dyslipidemia. "
3.	Obesity 01/01/2017 - "Here, we set out to compare effects of T3, 3,5-T2 and another form of T2 (3,3-T2) in a mouse model of diet-induced obesity and determined effects of T3 and 3,5-T2 on markers of classical insulin sensitization to understand how diiodothyronines influence blood glucose. "
4.	Liver Diseases (Liver Disease) 01/01/2018 - "In addition, the possible therapeutic use of mono- and diiodothyronines in metabolic and/or neoplastic liver disease will be discussed." 01/01/2018 - "More recently, evidence has been provided that some metabolites of thyroid hormones (TH), mono and diiodothyronines, could also play a role in the treatment of liver disease. "
5.	Depressive Disorder (Melancholia) 02/01/1981 - "Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression."